Phase II study of cabozantinib in patients with progressive glioblastoma: subset analysis of patients naive to antiangiogenic therapy.
published in: Neuro-Oncology
date of publication: 2017-08-14
main subject: angiogenesis inhibitor, glioblastoma
Cites articles 24
Date
Title
Article - wd:Q45069709